Log in
Enquire now
Carbon Biosciences

Carbon Biosciences

biotech company that engages in the novel parvovirus gene therapy

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
CEO
‌
Joel Schneider
0
Company Operating Status
Active
Crunchbase URL
crunchbase.com/organiz...sciences
Founded Date
June 2021
Full Address
131 Hartwell Ave., Lexington, MA 02421, United States
0
Funding Round Date
June 21, 2022
Funding Type
Series A
Series A
Industry
Biology
Biology
‌
Product Research
Biotechnology
Biotechnology
Technology
Technology
Investors
Solasta Ventures
Solasta Ventures
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation
Longwood Fund
Longwood Fund
Astellas Venture Management
Astellas Venture Management
Agent Capital
Agent Capital
UTokyo Innovation Platform
UTokyo Innovation Platform
Camford Capital
Camford Capital
Key People
‌
Robert Kotin Adjunct Professor
‌
Geeta Vemuri Partner BioVentures
‌
Chen Schor
Derek Yoon
Derek Yoon
Latest Funding Round Date
June 22, 2022
Latest Funding Round Amount (USD)
38,000,000
Latest Funding Type
Series A
Series A
LinkedIn URL
@company/carbonbiosciences
Location
Lexington, Massachusetts
Lexington, Massachusetts
0
Number of Employees (Ranges)
11 – 50
Pitchbook URL
pitchbook.com/profiles...494777-53
Total Funding Amount (USD)
38,000,000
Twitter URL
@carbonbiosci
Official Website
carbonbio.com
carbonbiosciences.com

Find more companies like Carbon Biosciences

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.